MegaPro Biomedical Co., Ltd (TPEX:6827)
18.45
-5.05 (-21.49%)
Nov 20, 2026, 1:53 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 1.19 billion as of November 20, 2026. It is the 31,914th most valuable company in the world and the 1,857th biggest in Taiwan. Its market cap has increased by 25.51% in one year.
Market Cap
1.19B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,857 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 1.19B, a decrease of -43.50%. That is a compound annual growth rate of -10.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.24B | 53.41% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.42B |
| Anti-Microbial Savior BioteQ | 1.35B |
| GenMont Biotech Incorporation | 1.33B |
| Synbio Tech | 1.32B |
| Greenyn Biotechnology | 1.21B |
| NeoCore Technology | 1.20B |
| TaiRx | 1.19B |
| Advagene Biopharma | 1.18B |